Legionellosis (Legionnaires' Disease and Pontiac Fever)

Legionellosis is an infection caused by Legionella bacteria — gram-negative rods that live naturally in freshwater and can colonize man-made water systems in buildings, hospitals, hotels, and cruise ships. It presents in two very different ways: Legionnaires’ disease, a severe pneumonia that can require hospitalization and carries a mortality rate of 5–10% even with treatment, and Pontiac fever, a milder self-limiting flu-like illness without pneumonia that resolves on its own. Legionnaires’ disease accounts for roughly 18,000 hospitalizations per year in the United States, though the true incidence is likely much higher because it is frequently under-diagnosed. People get it by inhaling aerosols from contaminated water sources — cooling towers, hot tubs, decorative fountains, hospital plumbing — not from person-to-person contact. Older adults, smokers, and people with weakened immune systems are at highest risk. Because Legionella doesn’t grow on standard respiratory cultures and requires specific media, it is commonly missed unless physicians specifically test for it. The best initial test is the urinary antigen, which rapidly detects the most common serotype (L. pneumophila serogroup 1).

Overview
Epidemiology
Pathophysiology
Sources and Transmission
Clinical Presentation
Diagnosis
Treatment
Outbreak Investigation and Water Management
Complications and Prognosis
Prevention
Research Papers
Connections
Featured Videos

1. Overview

Legionellosis encompasses two distinct clinical syndromes caused by bacteria of the genus Legionella. Legionnaires’ disease is an atypical pneumonia — a term that reflects both the organism’s intracellular nature and the fact that it behaves differently from classic bacterial pneumonia caused by organisms like Streptococcus pneumoniae. It is severe, requires hospitalization, and carries a case fatality rate of 5–10% in treated community-acquired cases, rising to up to 40% in immunocompromised patients or those who go untreated. Pontiac fever, by contrast, is a self-limiting flu-like illness: fever, myalgia, and headache develop 24–72 hours after exposure and resolve within 2–5 days without antibiotic treatment. The attack rate in Pontiac fever can be strikingly high — up to 90% of an exposed group — which often serves as an important outbreak clue.

Legionella pneumophila serogroup 1 is responsible for 70–90% of cases worldwide. More than 60 Legionella species have been identified, and over 20 are capable of causing human disease. The genus gets its name from one of the most famous outbreak investigations in the history of infectious disease: in July 1976, attendees of an American Legion convention at the Bellevue-Stratford Hotel in Philadelphia began falling ill with a mysterious severe pneumonia. Of the 221 people who became ill, 34 died. The outbreak galvanized the CDC, and within months investigators had identified a previously unknown gram-negative bacterium living in the hotel’s air conditioning cooling tower — an organism they named Legionella pneumophila. That investigation defined atypical pneumonia as a clinical category and inaugurated the modern era of environmental microbiology and waterborne disease control.

Because Legionella is an intracellular pathogen that does not grow on standard culture media, and because its presentation overlaps with other pneumonias, it remains one of the most commonly missed causes of serious respiratory infection. Understanding when to test for it — and what to test with — is among the highest-yield diagnostic skills in hospital medicine.

2. Epidemiology

The CDC estimates approximately 18,000 hospitalizations per year due to Legionnaires’ disease in the United States, but the actual burden is likely 2–3 times higher because the disease is frequently undiagnosed. Reported incidence has been rising steadily over the past two decades — a trend attributed to better diagnostic awareness, an aging population, and a growing number of immunocompromised individuals rather than a true increase in bacterial spread.

Legionellosis shows a clear seasonal pattern, with the peak occurring in late summer and fall, corresponding to higher ambient temperatures that favor bacterial growth in water systems and greater use of cooling equipment. The majority of cases are sporadic (no identified outbreak source), but outbreak investigations — which represent only 2–5% of cases — are epidemiologically critical because they reveal contaminated community or healthcare water systems.

Notable outbreaks in the United States include the 2015 South Bronx, New York cluster (138 cases, 16 deaths) traced to cooling towers in a concentrated industrial area, and outbreaks in Flint, Michigan linked to corroded infrastructure. Internationally, travel-associated Legionellosis is a recognized category, with hotels and cruise ships serving as recurrent sources. Healthcare-associated Legionellosis (HAI) is particularly dangerous: hospital-acquired cases carry mortality exceeding 30% because patients are already medically vulnerable and the diagnosis is often delayed.

Established risk factors include:

Age over 50 — the most consistent demographic risk factor
Smoking — the strongest modifiable risk factor; tobacco smoke damages the mucociliary clearance system that normally expels inhaled bacteria from the airways
Chronic lung disease (COPD, emphysema, bronchiectasis)
Diabetes mellitus
Chronic renal failure
Immunosuppression — solid organ transplant recipients, hematologic malignancy, patients on high-dose corticosteroids
Male sex (men are affected approximately twice as often as women in most series)

Legionella does not spread from person to person. Every case represents an independent environmental exposure event, which means household contacts of patients have no elevated risk and require no protective measures or prophylaxis.

3. Pathophysiology

Legionella is a facultative intracellular pathogen — it can survive outside cells but its pathological niche is inside the host cell, specifically the alveolar macrophage. This is the key fact that explains everything distinctive about the disease: why standard antibiotics often fail (many don’t penetrate cells), why the urinary antigen test is the best rapid diagnostic, and why the immune response in healthy people usually succeeds while it fails catastrophically in the immunocompromised.

Infection begins when a person inhales fine aerosols carrying Legionella organisms (or, in dysphagic patients, aspirates contaminated water). The bacteria reach the terminal airways and encounter alveolar macrophages — the lung’s resident immune phagocytes. Legionella enters macrophages via complement receptors and immediately begins subverting the cell’s normal killing mechanisms. Healthy macrophages destroy bacteria by acidifying the phagosome (the membrane-bound compartment around the bacterium) and fusing it with lysosomes containing destructive enzymes. Legionella blocks both steps.

The molecular machinery of this immune evasion is encoded on the Legionella Pathogenicity Island (LPI-1), which carries the Type IV secretion system — known as the Dot/Icm system. This molecular “syringe” injects more than 300 effector proteins directly into the macrophage cytoplasm. These effectors collectively hijack the host cell’s vesicular trafficking machinery, creating a specialized compartment called the Legionella-containing vacuole (LCV) that is replication-permissive rather than destructive. The bacterium replicates within this protected niche, eventually kills the macrophage, and then infects new macrophages, spreading through lung tissue.

A further challenge to control is biofilm formation. In water systems, Legionella grows within biofilms on pipe walls and in sediment, where it is protected from chlorination, heat treatment, and desiccation. This protection allows it to persist in building water systems for extended periods even when standard disinfection measures are in place.

4. Sources and Transmission

Legionella bacteria live naturally in freshwater environments at low concentrations. The problem arises when they colonize and amplify in man-made water systems that provide warm temperatures, stagnant water, sediment, and biofilm. The most important sources of outbreak-associated disease include:

Cooling towers — the HVAC systems that cool large commercial buildings circulate water and release aerosols from rooftops; the largest single source of community outbreak cases
Hot tubs and whirlpools — warm water combined with powerful jets creates ideal aerosol conditions; hot tub-associated outbreaks are common and often affect young, healthy adults
Hospital water systems — potable water distribution, ice machines, and respiratory therapy equipment (particularly humidifiers and nebulizers)
Decorative fountains — fine mist systems in shopping malls, casinos, and public spaces
Grocery store produce misters — a recognized but underappreciated source
Cruise ship water systems — a well-documented travel-associated risk
Evaporative condensers and cooling equipment in industrial settings
Potting soil — particularly relevant for Legionella longbeachae, which is the dominant species in Australia and New Zealand but rare in the United States

Transmission via drinking tap water is possible in patients who aspirate (particularly those with dysphagia, reduced consciousness, or nasogastric tubes) — it is aspiration of water into the lungs, not drinking per se, that allows infection. The bacterium grows optimally between 25–42°C. Maintaining hot water above 60°C at the heater and above 50°C at all outlets is one of the primary environmental control measures, because temperatures above 60°C rapidly kill Legionella.

5. Clinical Presentation

The incubation period for Legionnaires’ disease is 2–14 days, typically 2–10 days after exposure to the contaminated aerosol. The illness usually begins with a prodrome of high fever (often exceeding 39.5°C / 103°F), chills, malaise, myalgia, and headache that can mimic influenza. Within 1–2 days, lower respiratory symptoms emerge: initially a dry cough that may become productive, dyspnea, and pleuritic chest pain.

Several clinical features help distinguish Legionnaires’ disease from other pneumonias, though none is pathognomonic:

Gastrointestinal symptoms in approximately 50% of patients (diarrhea, nausea, vomiting, abdominal pain) — an unusual feature for a respiratory infection and an important diagnostic clue
Neurological involvement in severe cases: confusion, encephalopathy, and delirium occur in roughly 40% of hospitalized patients and can be a presenting feature
Relative bradycardia (pulse-temperature dissociation) — the pulse is inappropriately slow relative to the degree of fever; a classic teaching point for atypical pneumonia, though not universally present
Hyponatremia in 30–50% of patients — one of the most characteristic laboratory clues; may reflect SIADH or direct renal involvement by the bacterium
Elevated liver function tests in approximately 40% of patients
Hematuria and elevated creatinine reflecting renal involvement
Rhabdomyolysis with markedly elevated creatine kinase in severe cases

Chest X-ray and CT findings are non-specific but often striking: unilateral or bilateral infiltrates, frequently lobar in distribution, that tend to progress rapidly over the first 24–48 hours. Cavitation occurs in a minority of cases. Pleural effusion is present in approximately 30%.

A common misconception is that Legionnaires’ disease is a “walking pneumonia.” This term is more appropriate for Mycoplasma pneumoniae infection. Legionnaires’ disease is often severe enough to require intensive care unit admission, and it should be considered in any patient with community-acquired pneumonia severe enough to warrant hospitalization.

6. Diagnosis

The most important diagnostic principle for Legionellosis is that the disease will be missed unless specifically tested for. Legionella does not grow on standard blood agar, chocolate agar, or any of the routine culture media used in most clinical microbiology laboratories. It requires BCYE agar (buffered charcoal yeast extract), a specialized medium that must be specifically requested.

Urinary Antigen Test (UAT)

The urinary antigen test is the recommended first-line rapid diagnostic for suspected Legionellosis requiring hospitalization. It detects L. pneumophila serogroup 1 antigen in urine with a sensitivity of 70–90% and specificity exceeding 99%. Results are available within hours. Its principal limitation is that it detects only serogroup 1 (albeit the most common); non-serogroup-1 strains and other Legionella species will produce a negative result even in active infection. The antigen can remain detectable in urine for weeks after infection, which is useful for delayed diagnosis.

Culture on BCYE Agar

Sputum or lower respiratory tract specimens (bronchoalveolar lavage, bronchial wash) cultured on BCYE agar remain the gold standard because they identify all species and serogroups, allow antibiotic susceptibility testing, and provide organisms for molecular typing in outbreak investigations. Sensitivity is approximately 60–80% in good specimens; the test takes 3–10 days. Lower respiratory specimens are substantially superior to expectorated sputum.

Molecular Testing (PCR)

PCR-based detection of Legionella DNA in respiratory specimens is increasingly available and offers high sensitivity and specificity, particularly on BAL specimens. It is not yet universally standardized, and results can vary between laboratories. As part of multiplex respiratory panels, PCR is expanding the ability to detect non-serogroup-1 strains and non-pneumophila species.

Serology

Indirect immunofluorescence assay (IFA) measuring antibody titers requires paired acute and convalescent samples drawn 4–8 weeks apart to demonstrate a four-fold rise. This delay makes serology useless for acute clinical management but valuable for epidemiological confirmation of outbreak cases.

Direct Fluorescent Antibody (DFA)

DFA on respiratory specimens is rapid but insensitive (25–75%), limiting its clinical utility. It is used primarily in outbreak settings where rapid species identification is needed alongside culture.

Current IDSA/ATS guidelines recommend that all patients hospitalized with community-acquired pneumonia (CAP) should have both a urinary antigen test and respiratory culture for Legionella performed as part of their initial evaluation.

7. Treatment

The critical insight driving antibiotic selection for Legionnaires’ disease is that Legionella is an intracellular pathogen. Antibiotics must achieve high intracellular concentrations to reach the bacteria inside macrophages. Beta-lactam antibiotics (penicillins, cephalosporins, carbapenems) and aminoglycosides do not penetrate cells adequately and are not effective as monotherapy for Legionellosis, even though the organism is technically susceptible in vitro.

Fluoroquinolones: Preferred First-Line Agents

Levofloxacin 750 mg intravenously or orally once daily is the preferred agent in most current guidelines. Moxifloxacin 400 mg daily is an alternative. Fluoroquinolones achieve excellent intracellular concentrations, penetrate well into lung tissue and cerebrospinal fluid (important when neurological involvement is present), and have demonstrated superior outcomes versus macrolides in several observational studies. Duration: 5 days for mild-to-moderate disease; 14 days for severe disease, immunocompromised patients, or those with complications.

Azithromycin: Effective Alternative

Azithromycin is effective, achieves high intracellular concentrations, and is the preferred alternative for non-severe cases, pregnancy, or when fluoroquinolones are contraindicated. Erythromycin was the historical first-line agent but has been largely replaced by azithromycin due to better tolerability and pharmacokinetics.

Critical Supportive Care

Severe Legionnaires’ disease frequently requires intensive care unit management including mechanical ventilation for respiratory failure (ARDS develops in 10–20% of hospitalized cases), vasopressors for septic shock, and renal replacement therapy for acute kidney injury. Each 6-hour delay in initiating appropriate antibiotic therapy is associated with measurably increased mortality — making early recognition and rapid treatment initiation among the most impactful clinical decisions.

8. Outbreak Investigation and Water Management

Legionellosis is a nationally notifiable disease in the United States. Reporting any confirmed case to local and state public health authorities is mandatory. An outbreak is defined as two or more cases linked in time and place, and triggers an immediate epidemiological investigation.

Environmental investigation centers on identifying and sampling the suspected water source — typically cooling towers, but also hospital water systems, hot tubs, or other suspected sources. Environmental samples are cultured on BCYE agar and the clinical and environmental isolates are compared using whole genome sequencing (WGS), which has largely replaced older typing methods (PFGE, MLVA) and provides definitive epidemiological linkage.

Remediation of a confirmed contaminated source involves two complementary strategies:

Hyperchlorination: maintaining 2–5 parts per million residual free chlorine throughout the water system
Thermal disinfection: flushing the entire system at 70°C (160°F) or above, which rapidly kills Legionella at all sites in the plumbing

ASHRAE Standard 188 (adopted 2015, updated 2018) establishes mandatory requirements for Water Management Programs (WMPs) in buildings at elevated risk: hospitals, long-term care facilities, hotels, and any building with a cooling tower or complex water system. The standard requires written WMPs with control measures, monitoring schedules, corrective action protocols, and documentation. The CDC issued specific guidance in 2017 calling for all healthcare facilities to develop and implement Legionella WMPs, including regular environmental sampling, especially in units serving immunocompromised patients. Point-of-use filters (0.2-micron filters at faucets and showerheads) are recommended for immunocompromised inpatient units when facility water cannot be guaranteed Legionella-free.

9. Complications and Prognosis

Legionnaires’ disease is one of the more dangerous forms of community-acquired pneumonia and carries a significant complication burden even when treated appropriately:

Acute respiratory distress syndrome (ARDS): develops in 10–20% of hospitalized cases; requires mechanical ventilation
Septic shock: circulatory failure requiring vasopressors
Acute kidney injury: affects 15–20% of severe cases; often mediated by rhabdomyolysis, requiring renal replacement therapy in the most severe
Endocarditis: rare; case reports in prosthetic valve patients
Brain abscess: very rare; reported primarily in immunocompromised patients
Post-infectious fatigue and cognitive symptoms: prolonged recovery is common; many patients describe significant fatigue, difficulty concentrating, and reduced exercise tolerance for months after acute illness — a picture similar to post-pneumonia syndrome

Overall mortality depends heavily on where and how the infection was acquired:

Community-acquired, treated: 5–10%
Healthcare-associated: 15–30%
Immunocompromised: 40% or higher

Poor prognostic factors include age above 70, immunosuppression, delay in initiating appropriate antibiotics, need for mechanical ventilation, and multi-organ failure at presentation. Recovery from severe disease can take 3–6 months; some patients never return to their prior functional baseline.

10. Prevention

Unlike most vaccine-preventable infections, there is currently no licensed vaccine for Legionellosis, though research is ongoing. Prevention is entirely environmental and behavioral.

Building Water System Management

Maintain hot water storage at 60°C (140°F) or higher at the heater
Maintain hot water temperature at 50°C (122°F) or higher at all outlets (after a 1-minute flush)
Keep cold water below 20°C (68°F) where possible
Flush infrequently used outlets, dead legs, and recirculation loops regularly
Disinfect and inspect cooling towers at least twice yearly and after any period of inactivity
Implement ASHRAE Standard 188-compliant Water Management Programs for all high-risk facilities
Use point-of-use 0.2-micron filters in immunocompromised patient units

Individual Risk Reduction

Immunocompromised individuals should avoid hot tubs in hotels, gyms, and spas
Avoid decorative fountains and misting systems when immunocompromised
Smokers should be counseled that smoking is the strongest modifiable risk factor for Legionnaires’ disease
Travelers who develop pneumonia within 14 days of a hotel stay or cruise should inform their physician about travel history
No person-to-person precautions are needed — household contacts and healthcare workers are not at risk from a patient with Legionellosis

Public Health and Reporting

All confirmed cases must be reported to public health authorities. Prompt reporting enables investigation of potential shared sources before additional cases occur. Healthcare facilities should maintain Legionella Water Management Programs with regular environmental sampling and documented corrective action protocols, as recommended by CDC and required by ASHRAE 188 for high-risk buildings.

Back to Table of Contents

11. Research Papers

Key Research Papers

PubMed Research Searches

The following searches link directly to current, peer-reviewed literature on Legionellosis. Each opens a live PubMed query in a new tab.

Back to Table of Contents

Connections

Back to Table of Contents

Legionellosis (Legionnaires' Disease and Pontiac Fever)

Table of Contents

1. Overview

2. Epidemiology

3. Pathophysiology

4. Sources and Transmission

5. Clinical Presentation

6. Diagnosis

Urinary Antigen Test (UAT)

Culture on BCYE Agar

Molecular Testing (PCR)

Serology

Direct Fluorescent Antibody (DFA)

7. Treatment

Fluoroquinolones: Preferred First-Line Agents

Azithromycin: Effective Alternative

Critical Supportive Care

8. Outbreak Investigation and Water Management

9. Complications and Prognosis

10. Prevention

Building Water System Management

Individual Risk Reduction

Public Health and Reporting

11. Research Papers

Key Research Papers

PubMed Research Searches

Connections

Featured Videos